![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/23/2887380/0/en/Apnimed-Announces-a-Robust-Slate-of-Presentations-at-SLEEP-2024-Including-an-Analysis-of-the-Prevalence-of-Obesity-in-Obstructive-Sleep-Apnea.html
https://www.globenewswire.com/news-release/2024/05/09/2878714/0/en/Apnimed-Announces-Completion-of-Enrollment-in-Phase-3-LunAIRo-Study-of-AD109-the-Potential-First-Nighttime-Oral-Treatment-for-Obstructive-Sleep-Apnea.html
https://www.globenewswire.com/news-release/2024/05/07/2876690/0/en/Apnimed-Named-2024-Best-Places-to-Work-Company-by-the-Boston-Business-Journal.html
https://www.globenewswire.com/news-release/2024/04/03/2856873/0/en/Apnimed-to-Participate-in-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/03/06/2841350/0/en/Apnimed-to-Participate-in-the-Upcoming-Leerink-Partners-Global-Biopharma-Conference.html
https://www.globenewswire.com//news-release/2024/02/22/2833639/0/en/Apnimed-to-Participate-in-the-Upcoming-Evercore-ISI-2024-Emerging-Biotech-Conference.html
https://endpts.com/apnimed-a-late-stage-sleep-apnea-biotech-eyes-ipo-in-the-second-half/
https://endpts.com/apnimed-hires-pfizer-biohaven-veteran-as-chief-commercial-officer/
https://www.globenewswire.com//news-release/2024/01/22/2812888/0/en/Apnimed-Announces-New-Leadership-Appointments-as-the-Company-Builds-Its-Commercial-and-Human-Resource-Capabilities-in-Support-of-AD109-a-Potential-Nighttime-Oral-Treatment-for-Obst.html
https://www.globenewswire.com//news-release/2023/12/21/2799991/0/en/Apnimed-Announces-First-Patient-Dosed-in-SynAIRgy-the-Second-Phase-3-Clinical-Study-of-AD109-a-Potential-Nighttime-Oral-Treatment-for-Obstructive-Sleep-Apnea.html